Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
According to the latest research, the global Nicotinamide Mononucleotide market size was valued at USD 287.26 million in 2022 and is expected to expand at a CAGR of 27.33% during the forecast period, reaching USD 1224.2 million by 2028.
Nicotinamide mononucleotide is a nucleotide derived from ribose and nicotinamide. Ribonucleotide is the basic structural unit of nucleic acid RNA. It consists of a nicotinamide group, a ribose sugar, and a phosphate group. is a natural molecule present in all species. Nicotinamide mononucleotide (NMN) is one of the major precursors of nicotinamide adenine dinucleotide (NAD +), an essential enzyme for a variety of key cellular functions, including metabolism, DNA repair, cell growth, and survival.
The development of nicotinamide mononucleotide (NMN in the field of health care products and cosmetics)
Nicotinamide mononucleotide (NMN) not only has good safety and various biological activities but also has good thermal stability, so it has broad prospects in the fields of healthcare products and cosmetics. Currently, nicotinamide mononucleotide (NMN) is mainly used in the development of dietary supplements and other health products. For example, companies such as Herbalmax in the United States, Shinkowa in Japan, and GeneHarbor in Hong Kong, China have successively developed capsule/tablet products of brands such as Reinvigorator, Mirai Lab, and GeneHarbor. In addition, some countries have developed cosmetics such as NMN creams and NMN masks based on the anti-aging effect of nicotinamide mononucleotide (NMN), which has driven the rapid growth of the market demand for nicotinamide mononucleotide (NMN). It is expected that with the increasing awareness of global residents’ health care and the continuous improvement of the availability of downstream health care, cosmetics, and other products, the market size of nicotinamide mononucleotide (NMN) may continue to maintain a rapid growth trend.
Region Overview:
Asia Pacific had the highest growth rate of all regions
Company Overview:
GeneHarbor works on active pharmaceutical ingredients and/or intermediates via enzymatic approach, servicing pharma manufacturing. The company has developed a proprietary platform technology for production of various enzymes. The technology aims to reduce the cost & increase the life span of the enzymes. The company is developing a novel technology for purification of monoclonal antibodies. This will facilitate the development of monoclonal antibody drugs in the future.
Segmentation Overview:
By type, Content Above 98% segment accounted for the largest share of market in 2021.
Application Overview:
By application, the Health Care Products segment occupied the biggest share from 2017 to 2022.
This report elaborates on the market size, market characteristics, and market growth of the Nicotinamide Mononucleotide industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Nicotinamide Mononucleotide. The report also introduces players in the industry from the perspective of the value chain and looks into the leading companies.
Key Points this Global Nicotinamide Mononucleotide Market Report Include:
Market Size Estimates: Nicotinamide Mononucleotide market size estimation in terms of revenue and sales from 2018-2028
Market Dynamic and Trends: Nicotinamide Mononucleotide market drivers, restraints, opportunities, and challenges
Macro-economy and Regional Conflict: Influence of global inflation and Russia & Ukraine War on the Nicotinamide Mononucleotide market
Segment Market Analysis: Nicotinamide Mononucleotide market revenue and sales by type and by application from 2018-2028
Regional Market Analysis: Nicotinamide Mononucleotide market situations and prospects in major and top regions and countries
Nicotinamide Mononucleotide Market
Nicotinamide Mononucleotide Industry Chain: Nicotinamide Mononucleotide market raw materials & suppliers, manufacturing process, distributors by region, downstream customers
Nicotinamide Mononucleotide Industry News, Policies by regions
Nicotinamide Mononucleotide Industry Porters Five Forces Analysis
Key players in the global Nicotinamide Mononucleotide market are covered in Chapter 2:
Maac10 Formulas
Herbalmax
CELFULL
Kingdomway
GeneHarbor
Genex Formulas
Shinkowa Pharmaceutical
In Chapter 6 and Chapter 9, on the basis of types, the Nicotinamide Mononucleotide market from 2018 to 2028 is primarily split into:
Content Below 98%
Content Above 98%
In Chapter 7 and Chapter 10, on the basis of applications, the Nicotinamide Mononucleotide market from 2018 to 2028 covers:
Health Care Products
Cosmetics
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions from 2018 to 2028 are covered in Chapter 8 and Chapter 11:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
In summary, this report relies on sources from both primary and secondary, combines comprehensive quantitative analysis with detailed qualitative analysis, and pictures the market from a macro overview to micro granular segment aspects. Whatever your role in this industry value chain is, you should benefit from this report with no doubt.
Chapter Outline
This report consists of 12 chapters. Below is a brief guideline to help you quickly grasp the main contents of each chapter:
Chapter 1 first introduces the product overview, market scope, product classification, application, and regional division, and then summarizes the global Nicotinamide Mononucleotide market size in terms of revenue, sales volume, and average price.
Chapter 2 analyzes the main companies in the Nicotinamide Mononucleotide industry, including their main businesses, products/services, sales, prices, revenue, gross profit margin, and the latest developments/updates.
Chapter 3 is an analysis of the competitive environment of Nicotinamide Mononucleotide market participants. This mainly includes the revenue, sales, market share, and average price of the top players, along with the market concentration ratio in 2022 and the players' M&A and expansion in recent years.
Chapter 4 is an analysis of the Nicotinamide Mononucleotide industrial chain, including raw material analysis, manufacturing cost structure, distributors, and major downstream buyers.
Chapter 5 focuses on Nicotinamide Mononucleotide market dynamics and marketing strategy analysis, which include opportunities, challenges, industry development trends under inflation, industry news and policies analyzed by region, Porter's Five Forces analysis, as well as direct and indirect marketing, and the development trends of marketing channels.
Chapters 6-8 have segmented the Nicotinamide Mononucleotide market by type, application, and region, with a focus on sales and value from 2018 to 2023 from both vertical and horizontal perspectives.
Chapters 9-11 provide detailed Nicotinamide Mononucleotide market forecast data for 2023-2028, broken down by type and application, region, and major countries to help understand future growth trends.
Chapter 12 concludes with an explanation of the data sources and research methods. Verify and analyze through preliminary research to obtain final quantitative and qualitative data.
2022
Nicotinamide mononucleotide is a nucleotide derived from ribose and nicotinamide. Ribonucleotide is the basic structural unit of nucleic acid RNA. It consists of a nicotinamide group, a ribose sugar, and a phosphate group. is a natural molecule present in all species. Nicotinamide mononucleotide (NMN) is one of the major precursors of nicotinamide adenine dinucleotide (NAD +), an essential enzyme for a variety of key cellular functions, including metabolism, DNA repair, cell growth, and survival.
The development of nicotinamide mononucleotide (NMN in the field of health care products and cosmetics)
Nicotinamide mononucleotide (NMN) not only has good safety and various biological activities but also has good thermal stability, so it has broad prospects in the fields of healthcare products and cosmetics. Currently, nicotinamide mononucleotide (NMN) is mainly used in the development of dietary supplements and other health products. For example, companies such as Herbalmax in the United States, Shinkowa in Japan, and GeneHarbor in Hong Kong, China have successively developed capsule/tablet products of brands such as Reinvigorator, Mirai Lab, and GeneHarbor. In addition, some countries have developed cosmetics such as NMN creams and NMN masks based on the anti-aging effect of nicotinamide mononucleotide (NMN), which has driven the rapid growth of the market demand for nicotinamide mononucleotide (NMN). It is expected that with the increasing awareness of global residents’ health care and the continuous improvement of the availability of downstream health care, cosmetics, and other products, the market size of nicotinamide mononucleotide (NMN) may continue to maintain a rapid growth trend.
Region Overview:
Asia Pacific had the highest growth rate of all regions
Company Overview:
GeneHarbor works on active pharmaceutical ingredients and/or intermediates via enzymatic approach, servicing pharma manufacturing. The company has developed a proprietary platform technology for production of various enzymes. The technology aims to reduce the cost & increase the life span of the enzymes. The company is developing a novel technology for purification of monoclonal antibodies. This will facilitate the development of monoclonal antibody drugs in the future.
Segmentation Overview:
By type, Content Above 98% segment accounted for the largest share of market in 2021.
Application Overview:
By application, the Health Care Products segment occupied the biggest share from 2017 to 2022.
This report elaborates on the market size, market characteristics, and market growth of the Nicotinamide Mononucleotide industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Nicotinamide Mononucleotide. The report also introduces players in the industry from the perspective of the value chain and looks into the leading companies.
Key Points this Global Nicotinamide Mononucleotide Market Report Include:
Market Size Estimates: Nicotinamide Mononucleotide market size estimation in terms of revenue and sales from 2018-2028
Market Dynamic and Trends: Nicotinamide Mononucleotide market drivers, restraints, opportunities, and challenges
Macro-economy and Regional Conflict: Influence of global inflation and Russia & Ukraine War on the Nicotinamide Mononucleotide market
Segment Market Analysis: Nicotinamide Mononucleotide market revenue and sales by type and by application from 2018-2028
Regional Market Analysis: Nicotinamide Mononucleotide market situations and prospects in major and top regions and countries
Nicotinamide Mononucleotide Market
Competitive Landscape
and Major Players: Analysis of 10-15 leading market players, sales, price, revenue, gross, gross margin, product/service profile and recent development/updates, etc.Nicotinamide Mononucleotide Industry Chain: Nicotinamide Mononucleotide market raw materials & suppliers, manufacturing process, distributors by region, downstream customers
Nicotinamide Mononucleotide Industry News, Policies by regions
Nicotinamide Mononucleotide Industry Porters Five Forces Analysis
Key players in the global Nicotinamide Mononucleotide market are covered in Chapter 2:
Maac10 Formulas
Herbalmax
CELFULL
Kingdomway
GeneHarbor
Genex Formulas
Shinkowa Pharmaceutical
In Chapter 6 and Chapter 9, on the basis of types, the Nicotinamide Mononucleotide market from 2018 to 2028 is primarily split into:
Content Below 98%
Content Above 98%
In Chapter 7 and Chapter 10, on the basis of applications, the Nicotinamide Mononucleotide market from 2018 to 2028 covers:
Health Care Products
Cosmetics
Others
Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions from 2018 to 2028 are covered in Chapter 8 and Chapter 11:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
In summary, this report relies on sources from both primary and secondary, combines comprehensive quantitative analysis with detailed qualitative analysis, and pictures the market from a macro overview to micro granular segment aspects. Whatever your role in this industry value chain is, you should benefit from this report with no doubt.
Chapter Outline
This report consists of 12 chapters. Below is a brief guideline to help you quickly grasp the main contents of each chapter:
Chapter 1 first introduces the product overview, market scope, product classification, application, and regional division, and then summarizes the global Nicotinamide Mononucleotide market size in terms of revenue, sales volume, and average price.
Chapter 2 analyzes the main companies in the Nicotinamide Mononucleotide industry, including their main businesses, products/services, sales, prices, revenue, gross profit margin, and the latest developments/updates.
Chapter 3 is an analysis of the competitive environment of Nicotinamide Mononucleotide market participants. This mainly includes the revenue, sales, market share, and average price of the top players, along with the market concentration ratio in 2022 and the players' M&A and expansion in recent years.
Chapter 4 is an analysis of the Nicotinamide Mononucleotide industrial chain, including raw material analysis, manufacturing cost structure, distributors, and major downstream buyers.
Chapter 5 focuses on Nicotinamide Mononucleotide market dynamics and marketing strategy analysis, which include opportunities, challenges, industry development trends under inflation, industry news and policies analyzed by region, Porter's Five Forces analysis, as well as direct and indirect marketing, and the development trends of marketing channels.
Chapters 6-8 have segmented the Nicotinamide Mononucleotide market by type, application, and region, with a focus on sales and value from 2018 to 2023 from both vertical and horizontal perspectives.
Chapters 9-11 provide detailed Nicotinamide Mononucleotide market forecast data for 2023-2028, broken down by type and application, region, and major countries to help understand future growth trends.
Chapter 12 concludes with an explanation of the data sources and research methods. Verify and analyze through preliminary research to obtain final quantitative and qualitative data.
Years considered for this report:
Historical Years:
2018-2022Base Year:
2022Estimated Year:
2023Forecast Period:
2023-2028Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
